4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-027954
Chief Executive Officer acquired 26,667 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2017-12-01 | Grant or award | +26,667 | $19.12 | $509,873 | 133,560 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2017-12-01 | Grant or award · Stock Option (Right to Buy) | +260,000 | 260,000 | D | ||
Loading xslF345X03/doc4.xml…